None — 0 expert voices in KB; call rests on fundamentals + quant
Position sizing
Quality-income holding, ~1–3% if owned; not a high-conviction overweight
Next catalyst
2026-07-15 Q2'26 earnings (Street EPS $2.16)
Single biggest risk
Net-interest-income roll-over if the Fed cuts and deposits reprice — the recent earnings surge is partly rate-driven
One-line thesis. BNY is the world's largest custodian ($59.4T of assets under custody/administration) running at record efficiency — 1Q26 ROTCE ~29%, +42% EPS growth, a fresh $10B buyback — but after a +62% twelve-month run the stock sits right on the Street's consensus, so it is a quality utility to own for compounding income, not a mispriced bargain: a Watch, upgradable to Buy on a pullback.
◆ Synthos call — HoldBNY is a solid business largely reflected at ~$150 — fine to keep, no reason to chase; it gets interesting again below ~$128.
Downside Risk (lower = safer)
4/10 · Moderate
Fortress custody bank, low-teens forward P/E, beta ~1.07 — but rate-sensitive NII and a stock already +62% in 12mo.
Growth Quality
5/10 · Moderate
~7% forward EPS CAGR helped by buybacks; record ROTCE ~29%, but a low-single-digit organic-revenue franchise.
Exponential Potential
3/10 · Low
A 240-year-old scale utility at ~$101B cap; efficient and improving, but structurally not an exponential.
⚖ Reverse-DCF cross-checkMarket-implied growth ≈ 13%/yrTo justify today’s $147, earnings would have to compound roughly 13% a year for 10 years (9% discount rate). Analysts forecast ~17%/yr, so the market is pricing in LESS than what the Street expects.What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.
In plain English
BNY (its ticker on the exchange is BK; Synthos tracks it as BNY) is a 240-year-old "bank for banks." It doesn't lend to you and me much — instead it holds and keeps track of other people's money and securities: pension funds, asset managers, and governments pay BNY to safeguard, settle, and account for a staggering $59 trillion of assets. It's the plumbing of the financial system.
The business is doing well right now: profits per share jumped 42% last quarter, and the company is buying back a lot of its own stock. But the stock has already climbed 62% in a year, and at today's price it's trading right where Wall Street thinks it's worth. So you're not getting a discount — you're paying a fair price for a steady, well-run company.
Here's what our three scores mean in everyday terms:
Downside Risk 4/10 (fairly safe). Rock-solid, boring, low-drama business — but a chunk of the recent profit boom came from high interest rates, which can fade.
Growth Quality 5/10 (solid, not spectacular). It grows slowly and steadily, and squeezes out more profit through efficiency and buybacks — a reliable grinder, not a rocket.
Exponential Potential 3/10 (low). It's already enormous and about as mature as a company gets. Don't expect it to double quickly.
The one big worry: a good part of the recent earnings jump came from net interest income — the spread BNY earns on the cash it holds. If the Fed cuts rates and deposits reprice, that tailwind fades.
Verdict: Watch. A great franchise at a fair price. Own it for steady income, or wait for a dip to buy.
Solid = price · dashed = 50-day average · dotted = 200-day average · amber = 52-week high/low. Price above both averages is an uptrend.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Blue crossing above amber (bars flip green) = momentum turning up; below (bars red) = turning down. Bar height = the size of that gap.
Relative performance vs S&P 500 & its sector (XLF (sector)), set to 100 a year ago
Solid = BNY · dashed = S&P 500 · dotted = XLF (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
Price$146.62
Market cap$101B
P/E trailing6×
P/E FY26E / FY27E17× / 15×
EV / Sales-0.8×
EV / EBITDA-3.5×
Gross margin50.5%
Net margin14.7%
Dividend yield1.45%
Beta1.065
52-wk range$92 – $147
RSI(14)60
50 / 200-DMA$139 / $121
12-mo return+62% (SPY +21%)
Street target$146 ($122–$165)
Analyst grades8 Buy · 13 Hold · 0 Sell
FMP ratingB+
Next earnings2026-08-05
What the experts actually said 0 traceable claims on BNY · showing the highest-conviction voices
Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.
1. What it is
BNY (NYSE: BK; tracked here as BNY) is a ~240-year-old (founded 1784 by Alexander Hamilton) financial-infrastructure holding company — the world's largest custodian and securities-services firm. It is not primarily a lender; it is the back-office plumbing of global capital markets. Fiscal year ends December 31. It reports three core segments:
Securities Services — global custody, fund accounting, middle-office, transfer agency, issuer services. 1Q26 revenue $2.68B (+17% YoY), pre-tax margin 39%.
Market and Wealth Services — Pershing (clearing for RIAs/broker-dealers), Clearance & Collateral Management (a near-monopoly in US Treasury settlement), and Treasury Services.
Investment and Wealth Management — institutional and retail asset management ($2.1T AUM) plus wealth/estate planning.
Other — leasing, corporate treasury, trading.
Two scale metrics dwarf the P&L: assets under custody/administration (AUC/A) of $59.4T (+12% YoY) and AUM of $2.1T (+6%). BNY earns fees on those balances plus net interest income (NII) on the ~$318B of average client deposits it holds.
Revenue mix — the FMP product/geographic tags for a bank are noisy (they map "Financial Service," "Investment Advisory," etc., not the reporting segments), so treat these as directional:
By product tag (FY2025): "Financial Service" $10.10B · "Investment Advisory, Management & Administrative" $3.08B · "Distribution & Shareholder Service" $0.15B.
By geography (FY2025): United States $13.0B · EMEA $4.57B · a "Non-US" bucket $7.08B · Asia-Pacific $1.39B · Other $1.13B. The franchise is US-centric but genuinely global.
The cleaner read is management's own frame (§9): 1Q26 total revenue $5.41B (+13% YoY), split roughly total fee revenue $3.77B (+11%) and NII $1.37B (+18%).
2. The expert thesis (traceable)
There is no expert coverage of BNY in the Synthos knowledge base.total_claims = 0, net_bullish_voices = 0. None of the tracked investor/operator voices in our panel has an on-record, distilled claim on BNY.
Per House Standard, that means this verdict is fundamentals- and quant-driven, and carries no conviction rating. We will not manufacture a thesis or cite claim_ids that do not exist. If a tracked voice initiates coverage, this note will be re-scored.
What the market's professional analysts say (context, not Synthos conviction): 8 Buy / 13 Hold / 0 Sell → "Hold" consensus, price-target consensus $145.5 (high $165, low $122) — essentially at the current $146.62. The Street sees a well-run franchise already fairly priced. FMP's letter rating is B+ (overall score 3/5), dragged by rich price-to-book and P/E scores against a strong DCF/ROE.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
Score
0–10
The read
Downside Risk(lower = safer)
4 · Moderate-Low
Trades ~15× forward, beta ~1.07, systemically-important fortress balance sheet (CET1 11.0%, ROTCE 29%). Offsets: +62% run leaves less cushion, and NII is rate-sensitive.
Growth Quality
5 · Solid
~7% forward EPS CAGR — but the organic engine is low-single-digit fee growth; the rest is NII + a ~5%/yr buyback shrinking the share count. High-quality, low-octane.
Exponential Potential
3 · Low
A 240-year-old scale utility at ~$101B. Real efficiency gains, but no acceleration and no TAM that re-rates it into a multibagger.
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is the expected path, so a weighted blend would just restate it with false precision. The cases bound the range; the scores above summarize them.
Case
Key assumptions
Fair value
Bull
Markets stay firm (AUC/A & AUM keep compounding), fee momentum + positive operating leverage persist, NII holds as securities reprice higher. FY27E EPS beats to ~$10.5 (vs $9.74 cons); multiple re-rates to ~17.5×.
~$185 (+26%)
Base(our anchor)
Estimates roughly hit — FY27E EPS $9.74; a steady mid-single-digit compounder with record ROTCE earns a ~15.5× multiple.
~$150 (+2%)
Bear
Fed cuts bite NII, deposit betas rise, a market drawdown shrinks fee-generating balances. FY27E EPS stalls near ~$8.5; multiple de-rates to ~13×.
~$110 (−25%)
Synthos fair value = the base case, ~$150 (+2%), with the full $110–$185 span as the honest range. This anchor sits essentially on the Street's $145.5 consensus — after a 62% run, the easy money is behind it and BNY is priced about right. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). BNY is a mature scale utility — a decent compounder, but the opposite of an exponential:
Forward growth: revenue estimates actually step down in the FMP consensus (the analyst set models a normalization of NII from the ~$40B GAAP gross-interest-inflated line toward a ~$22–24B "net" revenue base by FY28–29). On the number that matters — EPS — consensus runs $8.84 (FY26E) → $9.74 (FY27E) → $10.75 (FY28E), a ~7% CAGR, and a chunk of that is the buyback shrinking the denominator, not organic growth.
Acceleration (2nd derivative) is negative. The 1Q26 +42% EPS surge is a high-water mark powered by an NII tailwind and cost discipline; the forward path decelerates to high-single-digit growth. This is normalization off a cyclical peak, not a durable ramp.
Room to run: at ~$101B market cap BNY is already the scale leader in a low-growth utility category. AUC/A "TAM" grows with global asset values (mid-single digits), not with disruption. A 3× from here is not a credible base case.
Reinvestment runway: modest — capex is ~$1.5B/yr (mostly technology/AI), and the dominant capital-return lever is the $10B buyback plus a 1.45% dividend, not high-return organic reinvestment.
Exponential Potential: Low (3/10). Own BNY for durable mid-single-digit compounding + capital return, not for a multibagger. A small, accelerating fintech with these returns on capital would score 8; BNY's size and maturity cap it at 3.
Note on the top line: FMP's "revenue" for BNY grosses up interest income (FY25 revenue $40.4B includes $25.6B gross interest income against $20.7B interest expense). The economically meaningful figure is management's total revenue — 1Q26 $5.41B — and net income.
Earnings (the clean read): FY25 net income $5.55B, EPS $7.41 diluted (up from $5.80 FY24, +28%). Q1'26 net income $1.63B, EPS $2.24 diluted, +42% YoY — a genuine acceleration on operating leverage.
Revenue drivers (1Q26): total revenue $5.41B (+13%); fee revenue $3.77B (+11%, on higher client activity, market values, FX); NII $1.37B (+18%, reinvesting securities at higher yields).
Margins & returns: 1Q26 pre-tax operating margin 37% (up from 32% a year ago), ROE 16.1%, ROTCE 29.3% — record profitability. TTM net margin (clean basis) ~26% of total revenue.
Efficiency: management delivered ~800 bps of positive operating leverage YoY — revenue growing materially faster than expense. This is the core of the bull case.
Balance sheet: a custody bank, so leverage optics differ from an industrial. CET1 11.0%, Tier-1 leverage 6.0%, LCR 111%, NSFR 131% — fortress capital and liquidity. Average deposits $318B (+13%). Reported "net debt" is deeply negative (−$98B) because of the cash/deposit base; net-debt/EBITDA is not a meaningful metric for this business.
Cash flow: GAAP operating cash flow is volatile for a bank (FY25 $6.7B, FY24 $0.7B) driven by trading-book working-capital swings; earnings and capital ratios are the better gauge.
6. Valuation — priced in or room?
On the metrics that matter for a bank, BNY is fairly-to-slightly-fully valued, not cheap, not egregious:
P/E: ~18× trailing, 16.6× FY26E, 15.1× FY27E, 13.6× FY28E — a reasonable multiple for a mid-single-digit EPS grower, roughly in line with custody-bank history.
Book value:2.26× book, ~4.4× tangible book ($33.37 TBV/share). That P/TBV is toward the high end of BNY's own range — justified only if ROTCE stays near the record ~29%. If ROTCE normalizes toward the low-20s as NII fades, the multiple looks stretched. This is the crux of the bear case.
Yield: dividend $2.12 (1.45%), payout ~29% — well-covered, plenty of room to grow, supplemented by the $10B buyback (~10% of the cap).
EV-based multiples are not meaningful here (FMP shows a negative enterprise value because client cash/deposits swamp debt) — ignore the EV/EBITDA line for a custodian.
Street targets (context): consensus $145.5, high $165, low $122 — the stock is trading at consensus, i.e. the market already reflects the good news. Our ~$150 base is a whisker above. Not a value buy; a quality-utility-at-fair-value hold.
7. Technicals (from the tech block)
Trend:up. $146.62 sits above the 50-DMA ($139.19) and 200-DMA ($121.49), 50 above 200 (golden-cross posture). MACD +1.91 (positive).
Location: just −0.5% off the 52-week high (~$147.29), +59% off the 52-week low ($92.09) — a leadership name pinned near highs, shallow max drawdown (−0.5% from peak in the window).
Momentum: RSI(14) ~60 — firm but not overbought (<70).
Relative strength: BNY +61.7% 12-mo vs SPY +20.6% and QQQ +30.3%; +21% 3-mo vs SPY +14%. Sustained outperformance of the market — impressive for a custody bank, and a caution flag on entry after such a move.
Read: technicals confirm the operating momentum but flag that the stock is extended after a 62% year. No golden-cross problem; the risk is buying the top of a big move. A pullback toward the rising 50-DMA (~$139) would be a lower-risk entry.
8. Moat & competitive position
BNY's moat is scale, switching costs, and systemic entrenchment. Custody is a winner-takes-most utility: it is operationally punishing to move trillions of dollars of assets between custodians, contracts are sticky and multi-year, and BNY's position in US Treasury clearance & collateral management is a near-monopoly (it and a handful of peers underpin the plumbing of the Treasury market). AUC/A of $59.4T is a barrier competitors cannot cheaply replicate. The trade-off is that this same maturity caps growth and gives clients fee-compression leverage.
Peer set (market cap): the direct custody/trust comps are State Street (STT) $47B and Northern Trust (NTRS) $33B; on the asset-management side BlackRock (BLK) $155B, Blackstone (BX) $96B, Ameriprise (AMP) $44B, T. Rowe Price (TROW) $25B, Principal (PFG) $24B, Franklin (BEN) $18B, Invesco (IVZ) $12B, plus smaller names (AMG, SEIC, JHG). Against STT and NTRS, BNY is the scale leader and currently the most profitable on ROTCE — the peer read supports "best-in-class custodian," not "cheap."
9. Management, capital allocation & guidance
Leadership: CEO Robin Vince (since 2022). The turnaround thesis — expense discipline + technology/AI investment driving positive operating leverage — is visibly working in the numbers (37% pre-tax margin, ~800 bps operating leverage, record ROTCE).
Capital allocation: shareholder-return-led. 1Q26 returned $1.4B to shareholders ($376M dividends + $983M buybacks) — an 87% total payout ratio — and the Board authorized a new $10B repurchase program (~10% of market cap). Dividend yield 1.45%, payout ~29% of earnings. This is a return-of-capital story, appropriate for a mature franchise.
Insider activity: the sampled 2026-04 filings show routine executive sales (Perez ~12.5k @ $137, McCarthy 30k @ $136.50, others small) alongside director stock-unit awards — normal comp-driven diversification at elevated prices, no alarming discretionary cluster, but worth noting insiders are net sellers into the run.
Management's own guidance (half-weighted — their own book): The 1Q26 earnings release (SEC 8-K, filed 2026-04-16) is a real earnings document. CEO Vince framed a "strong start to 2026" with record revenue $5.4B (+13%), 800+ bps of positive operating leverage, 37% pre-tax margin, 29% ROTCE, and EPS +42%, plus "the strongest quarterly sales performance in our history" and "several very strategic business wins." Management points to continued investment in "new products, capabilities, AI, and our people" and "executing on our long-term plan to unlock BNY's full potential." Note: the release reports results and tone rather than hard forward numeric guidance (a bank rarely guides EPS); treat the momentum framing as management's self-interested read, half-weighted.
10. Catalysts & what to watch
Next earnings: 2026-07-15 (Q2'26; Street EPS $2.16, revenue est ~$5.35B on the clean basis). Key lines: NII trajectory and deposit betas, fee growth, and whether ~800 bps operating leverage persists.
Net interest income: the swing factor. Watch the securities-reinvestment yield vs deposit repricing as the Fed's path evolves — the recent surge is partly rate-driven.
AUC/A and AUM flows: net new business vs outflows; AUM had cumulative net outflows offset by market appreciation (a soft spot).
Buyback pace: how fast the $10B authorization is deployed (share-count reduction is ~1–2 pts of the EPS story).
Operating leverage: sustained positive leverage is the whole re-rating thesis — a reversal would break it.
Thesis tripwires (what would change the call): NII declining two quarters running with rising deposit betas; operating leverage turning negative; ROTCE falling back toward the low-20s (which would un-justify the ~4.4× P/TBV); or sustained AUM outflows.
11. Key risks
Interest-rate / NII normalization (structural-cyclical): ~25% of revenue is NII; a Fed cutting cycle with rising deposit betas compresses the spread that drove the recent earnings surge. The single biggest risk.
Valuation after the run: +62% in 12 months, trading at consensus and ~4.4× tangible book — little margin for a disappointment; the easy re-rating is done.
Market-level exposure: fees scale with AUC/A and AUM, so an equity/bond drawdown mechanically shrinks the fee base.
Fee compression: custody is competitive and commoditizing at the margin; pricing power is limited versus large clients.
Regulatory / systemic: a globally-systemically-important bank (G-SIB) faces capital, TLAC, and operational-resilience requirements; an operational or cyber failure in critical market plumbing would be severe.
No expert coverage: the Synthos KB has zero traceable claims on BNY, so there is no independent-analyst conviction backstopping this quant/fundamental call — treat with commensurate humility.
12. Verdict, position sizing & monitoring
Watch. BNY is a genuinely high-quality franchise — the world's largest custodian, running at record efficiency (37% pre-tax margin, ~29% ROTCE, ~800 bps operating leverage, +42% EPS), returning ~87% of earnings via dividends and a fresh $10B buyback. The problem is price, not quality: after a +62% twelve-month run the stock trades right on the Street's $145.5 consensus and our ~$150 base case, at ~4.4× tangible book that already assumes record returns persist. There is no expert conviction in the KB to push it higher, and the NII tailwind that drove the surge is rate-sensitive. That is a fairly-valued great business — a Watch, not a Buy, upgradable on a pullback toward the ~$139 50-DMA or a demonstrated durability of operating leverage through a rate-cut cycle.
Sizing: if owned as a quality-income holding, ~1–3%; not a high-conviction overweight at this price.
Monitoring: re-underwrite on the §10 tripwires; formal re-score each earnings print. Logged as a tracked Synthos call as of 2026-07-03 at $146.62.
Single biggest risk: net-interest-income roll-over if the Fed cuts and deposits reprice — the recent earnings boom is partly a rate story.
Provenance & disclosures
Traceability: 0 KB claims, breadth 0 — no expert coverage in the Synthos KB. This is an explicitly fundamentals- and quant-driven note; no claim_ids are cited because none exist, and none were fabricated.
Data as-of: fundamentals 2026-03-31 (Q1'26) · estimates & prices 2026-07-02/03. Forward figures are analyst consensus (FMP), labeled as estimates.
Management caveat: the 1Q26 earnings-release commentary (SEC 8-K, 2026-04-16) is management's own book, half-weighted by design; it reports results and momentum rather than hard forward EPS guidance.
Ticker note: trades on the NYSE as BK; tracked in Synthos data as BNY. FMP's grossed-up "revenue" line for a bank is not economically meaningful — we anchor on management's total revenue and net income.
Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").